Edwards Lifesciences Corp. (EW) Misses Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $89.07 -1.13%
EPS Growth %: +10.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +10.4%
Financial Fact:
Diluted (in shares): 218.1M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q3 EPS of $0.38, $0.01 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $412.7 million versus the consensus estimate of $405.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Edwards Lifesciences faces stock risk ahead of trial results says Stifel
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
- Rithm Capital Corp. (RITM) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
